Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Cited by (1,002)

Items 701–800 of 1,002

1. Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features
   Yalan Lei, Rong Tang, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Qingcai Meng, Jie Hua, Xianjun Yu, Wei Wang et al. · 2021 · Bioengineered
2. Establishment of Pancreatobiliary Cancer Zebrafish Avatars for Chemotherapy Screening
   Mariana Tavares Barroso, Bruna Figueiredo Costa, Cátia Rebelo de Almeida, Mireia Castillo-Martín, Nuno Couto, Tânia Carvalho, Rita Fior · 2021 · Cells
3. Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis
   Signe E J Hansen, Anne Langsted, Anette Varbo, Christian Medom Madsen, Anne Tybjærg‐Hansen, Børge Grønne Nordestgaard · 2021 · European Journal of Epidemiology
4. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer
   Bilal Rah, Manzoor Ahmad Banday, Gh Rasool Bhat, Omar Javed Shah, Humira Jeelani, Fizalah Kawoosa, Tahira Yousuf, Dil Afroze · 2021 · World Journal of Gastroenterology
5. Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells
   Sumire Suzuki, Masato Ogawa, Masaya Miyazaki, Kohki Ota, Hiromi Kazama, Ayako Hirota, Naoharu Takano, Masaki Hiramoto, Keisuke Miyazawa · 2021 · Oncology Reports
6. Current status of non-surgical treatment of locally advanced pancreatic cancer
   Stavros Spiliopoulos, Maria Teresa Zurlo, Annachiara Casella, Letizia Laera, Giammarco Surico, Alessia Surgo, Alba Fiorentino, Nicola de’Angelis, Roberto Calbi, Riccardo Memeo et al. · 2021 · World Journal of Gastrointestinal Oncology
7. Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner
   C. Arnold Spek, Hella L. Aberson, JanWillem Duitman · 2022 · Biomedicines
8. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer.
   Miguel Angel Ortega, Leonel Pekarek, Cielo García Montero, Oscar Fraile‐Μartinez, Miguel A. Sáez, Ángel Asúnsolo, Miguel Ángel Álvarez-Mon, Jorge Monserrat, Santiago Coca, M. Val Toledo-Lobo et al. · 2022 · PubMed
9. ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer
   Ruizhe He, Jia-Hao Zheng, Hong‐Fei Yao, Dapeng Xu, Minwei Yang, Dejun Liu, Yongwei Sun, Yan‐Miao Huo · 2022 · Hepatobiliary & pancreatic diseases international
10. Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
    Julian Götze, Christine Nitschke, Faik Güntac Uzunoglu, Klaus Pantel, Marianne Sinn, Harriet Wikman · 2022 · Frontiers in Cell and Developmental Biology
11. Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer
    Mikaela Dell’Oro, Michala Short, Puthenparampil Wilson, Eva Bezak · 2020 · Cancers
12. Evaluating triage protocols for endoscopic ultrasound-guided fine needle biopsies of the pancreas
    Megan J. Fitzpatrick, Yasmin Genevieve Hernandez-Barco, Kumar Krishnan, Brenna W. Casey, Martha B. Pitman · 2020 · Journal of the American Society of Cytopathology
13. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling
    Teresa Starzyñska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber‐Lubecka, Filip Ambrożkiewicz, Michał Mikuła, Beata Kos‐Kudła, Jerzy Ostrowski · 2020 · International Journal of Molecular Sciences
14. Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro
    Gertrúd Forika, Andrea Balogh, Tamás Vancsik, Attila Zalatnai, Gábor Petővári, Zoltán Benyó, Tibor Krenács · 2020 · International Journal of Molecular Sciences
15. Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection
    SHINNOSUKE KAWAHARA, Toru Aoyama, Masaaki Murakawa, Rei Kanemoto, Daishi Takahashi, Yuto Kamioka, ITARU HASHIMOTO, Yukio Maezawa, Satoshi Kobayashi, Makoto Ueno et al. · 2024 · BMC Cancer
16. Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment
    Frank Arnold, Annachiara Del Vecchio, Zainab Hussain, Mara H. Sherman · 2026 · Nature reviews. Cancer
17. A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
    Christian Chapa González, Karina López, Kimberly Michelle Lomelí, Jorge A. Roacho-Pérez, Jazmín Cristina Stevens Barrón · 2022 · Life
18. Proteome and secretome analysis of pancreatic cancer cells
    Xiang Li, Hui Liu, Matthew D. Dun, Sam Faulkner, Xiaoming Liu, Chen Chen Jiang, Hubert Hondermarck · 2022 · PROTEOMICS
19. Mapping Organizational Changes of Fiber‐Like Structures in Disease Progression by Multiparametric, Quantitative Imaging
    Shuhao Qian, Jia Meng, Zhe Feng, Lingxi Zhou, Shenyi Jiang, Yalun Wang, Zitong Ye, Shuangmu Zhuo, Jianxin Chen, Xinjian Li et al. · 2022 · Laser & Photonics Review
20. Pre-Existing Psychological Disorders, Diabetes, and Pancreatic Cancer: A Population-Based Study of 38,952 Finns
    Peng Li, Yaoyue Hu, Ghislaine Scélo, Mikko Myrskylä, Pekka Martikainen · 2022 · Cancer Epidemiology
21. Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer
    Shuai Xu, Huilan Wang, Chao Xia, Jun Lv, Gang Zhang · 2022 · Pancreas
22. Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings
    James Alex Malcolm, MARK A. TACEY, Peter Gibbs, Belinda Lee, Hyun Soo Ko · 2023 · European Radiology
23. The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models
    Szandra Schwarcz, Patrik Kovács, Tündé Kovàcs, Gyula Ujlaki, Petra Nyerges, Karen Uray, Péter Bai, Edit Mikó · 2023 · Molecular Biology Reports
24. Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
    Xiaoling Zhang, Yuxin Zhou, Jiahe Hu, Xuefeng Yu, Haitao Xu, Zhichang Ba, Haoxin Zhang, Yanan Sun, Rongfang Wang, Xinlian Du et al. · 2023 · BMC Cancer
25. A Novel HOXA10 -Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
    Sophia G. Kisling, Pranita Atri, Ashu Shah, Jesse L. Cox, Sunandini Sharma, Lynette M. Smith, Dario Ghersi, Surinder K. Batra · 2023 · Clinical Cancer Research
26. EBF2 Links KMT2D‐Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN
    Bing Yao, Mengying Xing, Shixin Meng, Shang Li, Jingwan Zhou, Ming Zhang, Chen Yang, Shuang Qu, Yucui Jin, Hongyan Yuan et al. · 2023 · Advanced Science
27. Unveiling the potential anti‐cancer activity of calycosin against multivarious cancers with molecular insights: A promising frontier in cancer research
    Md Sohel, Fatema Tuj Zahra Shova, Md. Shahporan Shuvo, Taiyara Mahjabin, Md. Mojnu Mia, Dibyendu Halder, Hafizul Islam, Md. Roman Mogal, Partha Biswas, Hasi Rani Saha et al. · 2024 · Cancer Medicine
28. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
    Hannah Hisham Rashwan, A.M. Taher, H.A. Hassan, Aeshah A. Awaji, Caroline Joseph Kiriacos, R.A. Assal, Rana Ahmed Youness · 2024 · Pathology - Research and Practice
29. DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy
    Zhe Ma, Zhenxing Zhou, Wenwen Duan, Gaofeng Yao, Shimei Sheng, Sidou Zong, Xin Zhang, Chenyang Li, Yuanyuan Liu, Fengting Ou et al. · 2024 · Cancer Immunology Immunotherapy
30. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
    Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai · 2024 · Cells
31. The interplay between microRNAs and Nrf2 signaling in human cancers
    Reza Panahizadeh, Mohammad Amin Vatankhah, Ali Safari, Hesam Danesh, Negin Nazmi, Pourya Gholizadeh, Narges Soozangar, Farhad Jeddi · 2024 · Cancer Cell International
32. Calcium ion delivery by microbubble-assisted sonoporation stimulates cell death in human gastrointestinal cancer cells
    Dawid Przystupski, Dagmara Baczyńska, Joanna Rossowska, Julita Kulbacka, Marek Ussowicz · 2024 · Biomedicine & Pharmacotherapy
33. Mangiferin: An effective agent against human malignancies
    Nimra Irshad, Hammad Naeem, Muhammad Shahbaz, Muhammad Imran, Ahmed Mujtaba, Muzzamal Hussain, Waleed Al Abdulmonem, Suliman Abdallah Alsagaby, Tadesse Fenta Yehuala, Mohamed Abdelwahab Abdelgawad et al. · 2024 · Food Science & Nutrition
34. Investigating LETd optimization strategies in carbon ion radiotherapy for pancreatic cancer: a dosimetric study using an anthropomorphic phantom
    Filipa Baltazar, Friderike K. Longarino, Christina Stengl, Jakob Liermann, Stewart Mein, Jürgen Debus, Thomas Tessonnier, Andrea Mairani · 2024 · Medical Physics
35. Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics
    Ashok Kumar Balaraman, Ehssan H. O. Moglad, Muhammad Afzal, Marianesan Arockia Babu, Kavita Goyal, Rangaswamy Roopashree, Irwanjot Kaur, Sachin Kumar, MRavi Kumar, Ashish Singh Chauhan et al. · 2024 · Clinica Chimica Acta
36. Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysis
    Soraya Hernández-Hatibi, Carlos Borau, Neus Martínez‐Bosch, Pilar Navarro, José Manuel García‐Aznar, Pedro Enrique Guerrero · 2025 · APL Bioengineering
37. Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments
    Cankut Çubuk, Fatma Ezgi Can, María Peña-Chilet, Joaquı́n Dopazo · 2020 · Cells
38. Dysregulation of miR-638 in the progression of cancers
    Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho · 2021 · Pathology - Research and Practice
39. Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
    Yongde Luo, Xiaokun Li, Jianjia Ma, James L. Abbruzzese, Weiqin Lu · 2021 · Cancers
40. Future directions in drug development in pancreatic cancer
    Aurélien Lambert, Thierry Conroy, Michel Pierre Ducreux · 2021 · Seminars in Oncology
41. Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells
    Hajar Dahou, Marie-Albane Minati, Patrick Jacquemin, Mohamad Assi · 2021 · Antioxidants
42. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series
    Claudio Francesco Feo, Giulia Deiana, Chiara Ninniri, Giuseppe Cherchi, Paola Crivelli, Alessandro Fancellu, Giorgio Carlo Ginesu, Alberto Porcu · 2021 · World Journal of Surgical Oncology
43. Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies
    Maria J. Monroy‐Iglesias, Saoirse Olivia Dolly, Debashis Sarker, Kiruthikah Thillai, Mieke Van Hemelrijck, Aida Santaolalla · 2021 · Journal of Clinical Medicine
44. Stem/progenitor cells in normal physiology and disease of the pancreas
    Mario Enrique Alvarèz Fallas, Sergio Pedraza‐Arévalo, Ana-Maria Cujba, Teodora Manea, Christopher Lambert, Rosario Morrugares, Rocı́o Sancho · 2021 · Molecular and Cellular Endocrinology
45. Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location
    Min Kyu Sung, Yejong Park, Bong Jun Kwak, Eunsung Jun, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Song Cheol Kim · 2021 · Biomedicines
46. Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis
    Felix Gerhard Gassert, Sebastian Ziegelmayer, Johanna Luitjens, Florian T. Gassert, Fabian Tollens, Johann Rink, Marcus R. Makowski, Johannes Rübenthaler, Matthias Frank Froelich · 2021 · European Radiology
47. A study on fractional tumour–immune–vitamins model for intervention of vitamins
    Sunil Kumar, Ram Pratap Chauhan, Abdel‐Haleem Abdel‐Aty, Sayed F. Abdelwahab · 2022 · Results in Physics
48. Controversial role of γδ T cells in pancreatic cancer
    Fatemeh Nezhad Shamohammadi, Mahboubeh Yazdanifar, Mona Oraei, Mohammad Hossein Kazemi, Azam Roohi, Seyedeh Mahya Shariat Razavi, Farhad Rezaei, Farzad Parvizpour, Yalda Karamlou, Haideh Namdari · 2022 · International Immunopharmacology
49. Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma
    Eman M. Ragab, Doaa M. El Gamal, Tarek Mostafa Mohamed, Abeer A. Khamis · 2022 · European journal of medical research
50. Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study
    Inger Torhild Gram, Song‐Yi Park, Lynne Ross Wilkens, Loı̈c Le Marchand, Veronica Wendy Setiawan · 2022 · Cancer Causes & Control
51. Necroptosis activation is associated with greater methylene blue-photodynamic therapy-induced cytotoxicity in human pancreatic ductal adenocarcinoma cells
    Daria Raquel Queiroz de Almeida, Ancély Ferreira dos Santos, Rosangela A.M. Wailemann, Letícia Ferreira Terra, Vinícius M. Gomes, Gabriel Santos Arini, Ester Risério Matos Bertoldi, Eduardo M. R. Reis, Maurı́cio S. Baptista, Letícia Labriola · 2022 · Photochemical & Photobiological Sciences
52. TGF-β2 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma
    Hong Kyu Lee, Min-Woo Nam, Ryeo‐Eun Go, Jihye Koo, Tae Hun Kim, Jun-Eui Park, Kyung‐Chul Choi · 2023 · Biomedicine & Pharmacotherapy
53. Comparison of therapeutic efficacy and treatment costs of self-expandable metal stents and plastic stents for management of malignant biliary obstruction
    Renáta Bor, Anna Fábián, Mónika Szűcs, Anita Bálint, Mariann Rutka, Tibor Istvan Toth, László Czakó, Klaudia Farkas, Norbert Buzás, Ágnes Milassin et al. · 2023 · BMC Gastroenterology
54. Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia
    Ieva Skaraitė, Elias Maccioni, Vilma Petrikaitė · 2023 · International Journal of Molecular Sciences
55. Pancreatic Tumor‐Targeting Stemsome Therapeutics
    Jun‐Young Park, Jun Young Park, Yong‐Gyu Jeong, Joo‐Hwan Park, Yeon Ho Park, Sang‐Hyun Kim, Dongwoo Khang · 2023 · Advanced Materials
56. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib
    Na Yin, Hui Yu, Xiaodi Zhang, Xiaodan Lv · 2020 · Drug Design Development and Therapy
57. Endoscopic retrograde cholangiopancreatography guided interventions in the management of pancreatic cancer
    Muhammad Nadeem Yousaf, Hamid Ehsan, Ahsan Wahab, Ahmad Muneeb, Fizah S. Chaudhary, Richard P. Williams, Christopher James Haas · 2020 · World Journal of Gastrointestinal Endoscopy
58. Using Graph Representation Learning to Predict Salivary Cortisol Levels in Pancreatic Cancer Patients
    Guimin Dong, Mehdi Boukhechba, Kelly M. Shaffer, Lee Michael Ritterband, Daniel G. Gioeli, Matthew J. Reilley, Tri Minh Le, Paul Raymond Kunk, Todd W. Bauer, Philip I. Chow · 2021 · Journal of Healthcare Informatics Research
59. Graphene-Assisted Electrochemical Sensor for Detection of Pancreatic Cancer Markers
    Zhenglei Xu, Min‐Si Peng, Zhuliang Zhang, Haotian Zeng, Ruiyue Shi, Xiaoxin Ma, Lisheng Wang, Bihong Liao · 2021 · Frontiers in Chemistry
60. Unveiling the tumour-regulatory roles of miR-1275 in cancer
    Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho, Chee-Mun Fang · 2021 · Pathology - Research and Practice
61. Long Term Results of Pancreatectomy With and Without Venous Resection: A Comparison of Safety and Complications of Spiral Graft, End-to-End and Tangential/Patch Reconstruction Techniques
    Tiina Vuorela, Pirkka Vikatmaa, Arto Kokkola, Harri K. Mustonen, Aino Salmiheimo, Annika Eurola, Pekka Aho, Caj H. Haglund, Ilkka Kantonen, Hanna E. Seppänen · 2022 · European Journal of Vascular and Endovascular Surgery
62. Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models
    Chen, Chao-Yi, Yang, Yi-Feng, Wang, Paul C., Shan, Liang, Lin, Stephen, Chen, Po-Jung, Chen, Yi-Jung, Chiang, Han-Sun, Lin, Jaw-Town, Hung, Chi-Feng et al. · 2022 · Pharmaceuticals
63. Isolation, structural characterization, and molecular docking studies on the bioactive compound from n-Hexane extract of Emilia sonchifolia (L.) DC against the pancreatic cancer target Aurora 2 Kinase
    Pratibha Prabhakaran, Chella Perumal Palanisamy, Abirami Shanmugam, Prabhu Damodharan, Harshini Swaminathan, Dhivya Devaraj, Rathi Muthaiyan Ahalliya, Velliyur Kanniappan Gopalakrishnan · 2024 · Journal of Complementary and Integrative Medicine
64. Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment
    Immacolata Maietta, África González‐Fernández, Rosana Simón‐Vázquez · 2025 · Advanced Drug Delivery Reviews
65. Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells
    Hong Cao, Qiang Li, Jing Chen, Katherine M. Johnson, Mark A. McNiven, Gina L. Razidlo · 2021 · PLoS ONE
66. Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations
    Ondřej Uher, Veronika Caisová, Lucie Paďouková, Karolína Kvardová, Kamila Masáková, Radka Lencova, Andrea Frejlachova, Markéta Skaličková, Anna Venhauerova, Adéla Chlastáková et al. · 2021 · Cancer Immunology Immunotherapy
67. Impact of endoscopic ultrasound-guided radiofrequency ablation in managing pancreatic malignancy
    Cosmas Rinaldi Adithya Lesmana · 2023 · World Journal of Gastrointestinal Surgery
68. Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer
    Duancheng Guo, Long‐Yun Ye, Weiding Wu, Xianjun Yu, Kaizhou Jin · 2023 · Acta Biochimica et Biophysica Sinica
69. Synergistic antitumor efficacy of rMV-Hu191 and Olaparib in pancreatic cancer by generating oxidative DNA damage and ROS-dependent apoptosis
    Chudi Zhang, Jiang Li-hong, Xue Zhou, Yong-ping He, Ye Liu, Dongming Zhou, Yao Lv, Benqing Wu, Zhengyan Zhao · 2023 · Translational Oncology
70. A potential cure for tumor‐associated immunosuppression by Toxoplasma gondii
    Narges Lotfalizadeh, Soheil Sadr, Solmaz Morovati, Mohammadhassan Lotfalizadeh, Ashkan Hajjafari, Hassan Borji · 2023 · Cancer Reports
71. Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization
    Te‐Min Ke, Artitaya Lophatananon, Kenneth Ross Muir · 2024 · International Journal of Molecular Sciences
72. Temoporfin-Conjugated PEGylated Poly( N , N -dimethylacrylamide)-Coated Upconversion Colloid for NIR-Induced Photodynamic Therapy of Pancreatic Cancer
    Oleksandr Shapoval, Vitalii Patsula, David Větvička, Hana Engstová, Viktoriia Oleksa, Martina Kabešová, Taras Vasylyshyn, PAVLA POUCKOVA, Daniel Horák · 2024 · Biomacromolecules
73. METTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression – experimental studies
    Tingzhuang Yi, Chunming Wang, Xia Ye, Jie Lin, Cheng Lin, Fengzhen Qin, Wanlin Yang, Yulu Ye, Dengchong Ning, Jinyan Lan et al. · 2024 · International Journal of Surgery
74. Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential
    Khem Raj Limbu, Rashmi Bhandari Chhetri, Su-Bin Kim, Jitendra Shrestha, Yoon Sin Oh, Dong Jae Baek, Eun‐Young Park · 2024 · Cancer Cell International
75. An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum
    Rex Devasahayam Arokia Balaya, Partho Sen, Caroline W. Grant, Roman M. Zenka, Marimuthu Sappani, Lakshmanan Jeyaseelan, Arjun P. Athreya, Richard K. Kandasamy, Akhilesh Pandey, Seul Kee Byeon · 2024 · Journal of Gastroenterology
76. Deeply Implantable, Shape‐Morphing, 3D MicroLEDs for Pancreatic Cancer Therapy
    Jae Hee Lee, Chae Gyu Lee, Min Seo Kim, Seungyeob Kim, Myoung Song, Haohui Zhang, Eunbyeol Yang, Yoon Hee Kwon, Young-Hoon Jung, Dong Yeol Hyeon et al. · 2024 · Advanced Materials
77. Differences in treatment outcome between translational platforms in developing therapies for gastrointestinal cancers
    Katarzyna Wawrzak-Pienkowska, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, Michał Ciborowski, Krzysztof Kurek, Dariusz Pawlak · 2025 · European Journal of Pharmacology
78. The psychosocial impact of pancreatic cancer on caregivers: a scoping review
    Tara J. Anderson, Gary Mitchell, Gillian Prue, Susan B McLaughlin, Lisa Graham‐Wisener · 2025 · BMC Cancer
79. Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial
    Bart Geboers, Florentine E. F. Timmer, Danielle J. W. Vos, Hester J. Scheffer, Joyce Bakker, Alette H. Ruarus, Laurien G. P. H. Vroomen, Anita G.M. Stam, Sinéad M. Lougheed, Evelien Schouten et al. · 2025 · Journal for ImmunoTherapy of Cancer
80. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours
    Ylberta Kajtazi, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp · 2019 · Journal of Cancer Research and Clinical Oncology
81. VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers
    Yi Le, Hong Gao, William G. Richards, Lei Zhao, Ronald Bleday, Thomas E. Clancy, Zhenglun Zhu · 2020 · JCI Insight
82. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications
    So Jeong Lee, You-Na Sung, Sung Joo Kim, Seungbeom Shin, HyungJun Cho, Ralph H. Hruban, Seung‐Mo Hong · 2020 · Pancreatology
83. Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
    Jiujie Cui, Xiaochen Zhang, Shuli Qu, Liwei Wang · 2020 · Expert Review of Pharmacoeconomics & Outcomes Research
84. Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
    Julia R. Naso, James Thomas Topham, Joanna M. Karasinska, Michael K.C. Lee, Steve E. Kalloger, Hui‐Li Wong, Jessica Nelson, Richard A. Moore, Andrew J. J. Mungall, Steven J.M. Jones et al. · 2020 · Cancer Medicine
85. A Quality Assessment of the Information Accessible to Patients on the Internet About the Whipple Procedure
    Hussein H. Khachfe, Mohamad A. Chahrour, Joseph R. Habib, Jun Yu, Faek R. Jamali · 2021 · World Journal of Surgery
86. Transcriptome Analysis of Subcutaneous Adipose Tissue from Severely Obese Patients Highlights Deregulation Profiles in Coding and Non-Coding Oncogenes
    Federica Rey, Letizia Messa, Cecilia Pandini, Rossella Launi, Bianca Barzaghini, Giancarlo Micheletto, Manuela Teresa Raimondi, Simona Bertoli, Cristina Cereda, Gianvincenzo Zuccotti et al. · 2021 · International Journal of Molecular Sciences
87. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
    Consuelo Gajate, Odile Gayet, Nicolas Alejandro Fraunhoffer, Juan Iovanna, Nelson Dusetti, Faustino Mollinedo · 2021 · Cancers
88. A small molecule inhibits pancreatic cancer stem cells
    Jayanta Das, Madhumita Das, Mayur Doke, Stanislaw F. Wnuk, Rose Mary Stiffin, Marco Andres Ruiz, Jonathan P. Celli · 2021 · International Journal of experimental research and review
89. Pancreas and Adverse Drug Reactions: A Literature Review
    Konrad Sosnowski, Piotr Nehring, Adam M. Przybyłkowski · 2022 · Drug Safety
90. The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
    Hao Xin Lu, Liyan Zheng, Lingyan Wu, Jun Chen, Na Xu, Sui-Cai Mi · 2022 · Frontiers in Oncology
91. The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
    Florian Nino Loch, Carsten Kamphues, Katharina Beyer, Christian Schineis, Wael Rayya, Johannes Christian Lauscher, David A. Horst, Mihnea Paul Dragomir, Simon Schallenberg · 2023 · International Journal of Molecular Sciences
92. Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancreatic cancer through bioinformatics approaches
    Richa Das, Shreni Agrawal, Pradeep Kumar, Amit Kumar Singh, Praveen Kumar Shukla, Indrani Bhattacharya, Kavindra Nath Tiwari, Sunil Kumar Mishra, Amit Kumar Tripathi · 2023 · 3 Biotech
93. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients
    Yuzhou Huang, Shurui Zhou, Yanji Luo, Jinmao Zou, Yaqing Li, Shaojie Chen, Ming Gao, Kaihong Huang, Guoda Lian · 2023 · Radiation Oncology
94. The Association Between Oral Anaerobic Bacteria and Pancreatic Cancer
    Mesut Öğrendik · 2023 · World Journal of Oncology
95. Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer
    Iris J. M. Levink, Maurice P.H.M. Jansen, Zakia Azmani, Wilfred F. J. van IJcken, Ronald van Marion, Maikel Petrus Peppelenbosch, Djuna L. Cahen, Gwenny Manel Fuhler, Marco J. Bruno · 2023 · International Journal of Molecular Sciences
96. PD‐L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self‐Delivery
    Chanda Bhandari, Azophi Moffat, Nimit Shah, Adil R. Khan, Maxwell Bortei Quaye, John Fakhry, Siddharth Reddy Soma, Austin Nguyen, Menitte Eroy, Ashritha Malkoochi et al. · 2024 · Advanced Healthcare Materials
97. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis
    Jinju Liu, Chaoyu Zhu, Lingzhi Zhang, Hongmei Lu, Zhen Wang, Jian Lv, Changru Fan · 2020 · Human Cell
98. MicroRNA‑23b‑3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF‑κB signaling pathways
    Yunan Zhang, Dayang Chen, Guoqiang Zhang, Xiongbo Wu, Liang-Yun Zhou, Yexin Lin, Junli Ding, Fangmei An, Qiang Zhan · 2020 · Oncology Letters
99. Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics
    Cristina Jiménez‐Luna, Ariadna Martín-Blázquez, Carmelo Diéguez-Castillo, Caridad Díaz, Martin Jl, Olga Genilloud, Francisca Vicente, José Pérez del Palacio, Jose Carlos Prados, Octavio Caba · 2020 · Metabolites
100. The Unique Microbiome and Immunity in Pancreatic Cancer
     Xin Wei, Chunlei Mei, Xixi Li, Yingjun Xie · 2021 · Pancreas